[Therapy of pediatric infections with cefixime].
In a pilot study with a limited number of patients the efficacy and tolerance of cefixime, a new oral cephalosporin antibiotic, were investigated in 15 children with the clinical diagnosis of bacterial respiratory tract infection, otitis media or urinary tract infection. The dosage was 2 x 4 mg/kg body weight daily for a period of seven to 11 days. Clinical efficacy was good in 13 cases, and subjective tolerance was good in all cases. The results support the assumption that cefixime is suited for the treatment of children with bacterial infections of the airways and urinary tract with sensitive pathogens.
Helwig
H
H
Fachabteilung für Kinderheilkunde und Jugendmedizin des St.-Josefs-Krankenhauses, Freiburg, Germany.
D000890:Anti-Infective Agents / Q000627:therapeutic use*; D001991:Bronchitis / Q000188:drug therapy; D020682:Cefixime; D002439:Cefotaxime / Q000031:analogs & derivatives* / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D006801:Humans; D008199:Lymphadenitis / Q000188:drug therapy; D010033:Otitis Media / Q000188:drug therapy*; D011014:Pneumonia / Q000188:drug therapy; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D012852:Sinusitis / Q000188:drug therapy; D014552:Urinary Tract Infections / Q000188:drug therapy*
D000890:Anti-Infective Agents; D020682:Cefixime; D002439:Cefotaxime
Therapie pädiatrischer Infektionen mit Cefixim.